TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28508306

Group type: EXPERIMENTAL
Intervention: Brimonidine Tartrate 0.1% ophthalmic solution
Number of subjects: 152

Group type: COMPARATOR
Intervention: Timolol Maleate 0.5% ophthalmic solution
Number of subjects: 152
Study: 25103271

Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT)
Number of subjects: 108
Study: 23294191

Group type: EXPERIMENTAL
Intervention: Modified Atkins diet
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control (no dietary intervention)
Number of subjects: 102
Study: 21962451

Group type: EXPERIMENTAL
Intervention: Intravenous alendronate (125 μg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Oral alendronate (35 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both intravenous and oral alendronate
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Adverse events during the study
Number of subjects: 24
Study: 18974581

Group type: EXPERIMENTAL
Intervention: Oral calcitriol for eight weeks
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 16953895

Group type: EXPERIMENTAL
Intervention: SaphLITE Retractor System (n = 100)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Clearglide Endoscopic Vessel Harvesting System (n = 100)
Number of subjects: 200
Study: 12827224

Group type: EXPERIMENTAL
Intervention: Raloxifene plus MFP (60 mg/day raloxifene HCl and 20 mg/day fluoride ions)
Number of subjects: 596

Group type: COMPARATOR
Intervention: MFP alone (20 mg/day fluoride and placebo)
Number of subjects: 596

Group type: EXPERIMENTAL
Intervention: Raloxifene plus MFP
Number of subjects: 596

Group type: COMPARATOR
Intervention: MFP alone
Number of subjects: 596
Study: 11096443

Group type: EXPERIMENTAL
Intervention: Standard therapy plus adjuvant gene therapy during surgery
Number of subjects: 248

Group type: COMPARATOR
Intervention: Standard therapy (surgical resection and radiotherapy)
Number of subjects: 248
Study: 9393252

Group type: EXPERIMENTAL
Intervention: Gamma probe-directed selective lymph node biopsy
Number of subjects: 63
Study: 7963512

Group type: EXPERIMENTAL
Intervention: Maximum cuff pressure of 300 mmHg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Maximum cuff pressure of 175 mmHg
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no sphygmomanometric recordings)
Number of subjects: 72
Study: 3655512

Group type: EXPERIMENTAL
Intervention: Lateral subcutaneous sphincterotomy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Anal dilatation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (20 control subjects)
Number of subjects: 20
Study: 29265838

Group type: EXPERIMENTAL
Intervention: Intervention condition (interactive online modules)
Number of subjects: 1645

Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 1645
Study: 27680325

Group type: EXPERIMENTAL
Intervention: Exercise intervention (three 60‐min sessions/week of combined aerobic and strength training and pelvic floor exercises)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 60
Study: 24411709

Group type: EXPERIMENTAL
Intervention: Doxycycline (100 mg daily)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study: 21895462

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) intervention (n=27)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (n=21)
Number of subjects: 48
Study: 20835692

Group type: EXPERIMENTAL
Intervention: PEEP of +7 cm H₂O
Number of subjects: 80

Group type: COMPARATOR
Intervention: Zero end-expiratory pressure (APL valve opened)
Number of subjects: 80
Study: 18183936

Group type: EXPERIMENTAL
Intervention: Bovine colostrum-based immune milk products
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immunizing cows with pathogens or their antigens
Number of subjects: 0
Study: 16361671

Group type: EXPERIMENTAL
Intervention: Achromatic automated perimetry (AAP)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Short wavelength automated perimetry (SWAP)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Frequency doubling perimetry (FDP)
Number of subjects: 51
Study: 12397469

Group type: EXPERIMENTAL
Intervention: [(11)C]acetate PET
Number of subjects: 36
Study: 10326536

Group type: EXPERIMENTAL
Intervention: ALM + BCG (1 mg ALM mixed with BCG)
Number of subjects: 3637

Group type: COMPARATOR
Intervention: BCG alone
Number of subjects: 3637

Group type: EXPERIMENTAL
Intervention: ALM + BCG
Number of subjects: 3637
Study: 7661605

Group type: EXPERIMENTAL
Intervention: Thalidomide (100 mg/d)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 2718759

Group type: EXPERIMENTAL
Intervention: Brushing with chewing sticks and toothpaste
Number of subjects: 0

Group type: COMPARATOR
Intervention: Brushing with chewing sticks only
Number of subjects: 0
Study: 766798

Group type: EXPERIMENTAL
Intervention: R & S 218‐M 0.56 mg/70 kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: R & S 218‐M 0.35 mg/70 kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Morphine sulfate 10.5 mg/70 kg
Number of subjects: 0
Study: 6789777

Group type: EXPERIMENTAL
Intervention: Topically applied chemotherapeutic drugs (e.g., thiotepa, fluorouracil, betamethasone valerate)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Topically applied chemotherapeutic drugs
Number of subjects: 30
Study: 31093866

Group type: EXPERIMENTAL
Intervention: Microfluidic chip method
Number of subjects: 428

Group type: COMPARATOR
Intervention: Density gradient method
Number of subjects: 428
Study: 30133419

Group type: EXPERIMENTAL
Intervention: Deep-slow breathing (DSB) with slow stretching patterns, performed with eyes closed
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Slow stretching with DSB
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: All stretching patterns
Number of subjects: 32
Study: 26888692

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 114
Study: 25299069

Group type: EXPERIMENTAL
Intervention: RBP-8000
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 22808006

Group type: EXPERIMENTAL
Intervention: 40 mg/day simvastatin
Number of subjects: 148
Study: 19434360

Group type: COMPARATOR
Intervention: 20 mg/day omeprazole
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: 5 mg/day ilaprazole
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: 10 mg/day ilaprazole
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: Both drugs (ilaprazole and omeprazole)
Number of subjects: 518
Study: 18693810

Group type: EXPERIMENTAL
Intervention: Natural Language Processing methods to detect trends in medication usage
Number of subjects: 0
Study: 15013946

Group type: EXPERIMENTAL
Intervention: Peptide YY3-36 (PYY3-36) infusion
Number of subjects: 2
Study: 11762428

Group type: EXPERIMENTAL
Intervention: Antidepressant discontinuation during week 8 of 12-week group CBT treatment
Number of subjects: 21

Group type: COMPARATOR
Intervention: Cognitive behavioral treatment (CBT)
Number of subjects: 21
Study: 9826883

Group type: EXPERIMENTAL
Intervention: Bath temperature of 37 degrees C (98.6 degrees F) with UVA doses ranging from 0.5 to 5.5 J/cm2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower temperatures (below 37 degrees C)
Number of subjects: 0
Study: 8121074

Group type: EXPERIMENTAL
Intervention: 99mTc‐MAG3
Number of subjects: 506
Study: 2913139

Group type: EXPERIMENTAL
Intervention: Theophylline (serum levels of 10 to 20 mg/L)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 1215448

Group type: EXPERIMENTAL
Intervention: Caffeine (300 mg/70 kg)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Caffeine (300 mg/70 kg) + Ethanol (0.75 g/kg)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo for Caffeine
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo for Ethanol
Number of subjects: 68
Study: 30585145

Group type: EXPERIMENTAL
Intervention: Social marketing intervention (community events, educational materials, radio broadcasts)
Number of subjects: 568

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 568
Study: 27311739

Group type: EXPERIMENTAL
Intervention: Combination therapy (VR-based motivational visuomotor feedback training with levodopa)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control group (levodopa alone)
Number of subjects: 4
Study: 25302624

Group type: EXPERIMENTAL
Intervention: CZP 200 mg every 2 weeks
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: CZP 400 mg every 4 weeks
Number of subjects: 209

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: CZP 200 mg and 400 mg
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: CZP 200 mg, 400 mg, and placebo
Number of subjects: 209
Study: 23136842

Group type: EXPERIMENTAL
Intervention: Halothane anesthesia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isoflurane anesthesia
Number of subjects: 0
Study: 21663632

Group type: EXPERIMENTAL
Intervention: First-line HAART
Number of subjects: 188
Study: 19372000

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (sham procedure)
Number of subjects: 60
Study: 16684702

Group type: EXPERIMENTAL
Intervention: Auditory steady-state response (ASSR) applied to electric response audiometry (ERA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ASSR-ERA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional pure-tone audiometry
Number of subjects: 0
Study: 14724869

Group type: EXPERIMENTAL
Intervention: Topical triple antibiotic ointment (TAO)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Mupirocin ointment
Number of subjects: 99
Study: 11593073

Group type: EXPERIMENTAL
Intervention: CX516 added to clozapine
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 9686856

Group type: EXPERIMENTAL
Intervention: Diode laser
Number of subjects: 40

Group type: COMPARATOR
Intervention: Argon green laser
Number of subjects: 40
Study: 8082050

Group type: EXPERIMENTAL
Intervention: 1 g/day of elemental calcium in the form of calcium pidolate
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (not treated)
Number of subjects: 72
Study: 2698444

Group type: EXPERIMENTAL
Intervention: Primary prevention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Public health strategies
Number of subjects: 0
Study: 1269351

Group type: EXPERIMENTAL
Intervention: Severe dehydration and reorientation of nursing personnel to delay catheterization
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Fluid restriction
Number of subjects: 500
Study: 30377895

Group type: EXPERIMENTAL
Intervention: Respiratory biofeedback condition (visual feedback paired to breathing)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control feedback placebo condition (visual feedback not paired to breathing)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control no-feedback condition (no visual feedback used)
Number of subjects: 0
Study: 28799056

Group type: EXPERIMENTAL
Intervention: Single-dose botulinum toxin type A (BTX-A) injection of 70 to 100 U
Number of subjects: 100

Group type: COMPARATOR
Intervention: Repeated-dose botulinum toxin type A (BTX-A) injection of 50 to 70 U initially, followed by another of equal volume 2 weeks later
Number of subjects: 100
Study: 26268673

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Occipital nerve field stimulation (ONFS)
Number of subjects: 9
Study: 24500540

Group type: EXPERIMENTAL
Intervention: Impact + Resistance Training (POWIR)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Exercise Placebo Program (FLEX)
Number of subjects: 51
Study: 21164169

Group type: EXPERIMENTAL
Intervention: DDAVP (1 μg/kg, intravenous)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Saline solution (placebo)
Number of subjects: 28
Study: 19552493

Group type: EXPERIMENTAL
Intervention: Post-fracture use of prescribed calcium plus vitamin D supplements
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Post-fracture use of anti-osteoporotic drugs concomitantly with calcium plus vitamin D
Number of subjects: 221

Group type: COMPARATOR
Intervention: Neither anti-osteoporotic drugs nor prescribed calcium and vitamin D
Number of subjects: 221
Study: 17200250

Group type: EXPERIMENTAL
Intervention: SunSafe in the Middle School Years program (intervention)
Number of subjects: 1927

Group type: COMPARATOR
Intervention: Control communities (control)
Number of subjects: 1927
Study: 15280750

Group type: EXPERIMENTAL
Intervention: p-GlcNAc patch
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 33
Study: 11552913

Group type: EXPERIMENTAL
Intervention: Nitazoxanide (100 mg b.d. for age 2-3 years; 200 mg b.d. for age 4-11 years)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Metronidazole (125 mg b.d. for age 2-5 years; 250 mg b.d. for age 6-11 years)
Number of subjects: 110
Study: 8998124

Group type: EXPERIMENTAL
Intervention: Low-dose recombinant human growth hormone (0.5 international units/kg per week)
Number of subjects: 10
Study: 8491104

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard General Practitioner Care
Number of subjects: 0
Study: 3122881

Group type: EXPERIMENTAL
Intervention: Night spent admitting emergency cases
Number of subjects: 12

Group type: COMPARATOR
Intervention: Night spent on call
Number of subjects: 12

Group type: COMPARATOR
Intervention: Night spent off duty
Number of subjects: 12
Study: 29301450

Group type: EXPERIMENTAL
Intervention: SonoVue (1.5 ml) before HIFU ablation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Saline (1.5 ml) before HIFU ablation
Number of subjects: 120
Study: 27731374

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT, 3 min intervals at 80% and 40% VO2max, n=20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT, sustained 60% VO2max, n=20)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no exercise intervention, n=20)
Number of subjects: 60
Study: 25586282

Group type: EXPERIMENTAL
Intervention: Levosimendan (loading dose of 15 μg/kg/min for 20 minutes, maintenance dose of 0.2 μg/kg/min for 6 hours before anesthetic induction)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Dopamine (10 μg/kg/min) and/or dobutamine (10 μg/kg/min) during weaning from cardiopulmonary bypass
Number of subjects: 115
Study: 22456451

Group type: COMPARATOR
Intervention: fMRI activity during face-name paired associative encoding memory paradigm
Number of subjects: 24
Study: 19853987

Group type: EXPERIMENTAL
Intervention: Robotic approach
Number of subjects: 41

Group type: COMPARATOR
Intervention: Open approach
Number of subjects: 41
Study: 18669722

Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg
Number of subjects: 310

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 310
Study: 15562385

Group type: EXPERIMENTAL
Intervention: Alendronate (5 mg/d)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Alfacalcidol (1 microg/d)
Number of subjects: 28
Study: 12569285

Group type: EXPERIMENTAL
Intervention: Hypoxic pelvic and limb perfusion with 50 mg/m² of melphalan
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Hypoxic pelvic and limb perfusion with 50 mg/m² of melphalan and 25 mg/m² of mitomycin C
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Hypoxic pelvic and limb perfusion (both regimens)
Number of subjects: 17
Study: 10551573

Group type: COMPARATOR
Intervention: 30% oxygen, balance nitrogen
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: 80% oxygen, balance nitrogen
Number of subjects: 231
Study: 8558148

Group type: EXPERIMENTAL
Intervention: Entacapone (200 mg) with levodopa
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo with levodopa
Number of subjects: 0
Study: 1593243

Group type: EXPERIMENTAL
Intervention: Intervention clinics
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control clinics
Number of subjects: 18
Study: 3931495

Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 40

Group type: COMPARATOR
Intervention: Methohexitone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both
Number of subjects: 40
Study: 30204515

Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA injections
Number of subjects: 0
Study: 29992713

Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control
Number of subjects: 37
Study: 27618854

Group type: EXPERIMENTAL
Intervention: Sacubitril/Valsartan
Number of subjects: 8399

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 8399
Study: 26195199

Group type: EXPERIMENTAL
Intervention: Patient decision aid (P-DA)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 74
Study: 23577077

Group type: EXPERIMENTAL
Intervention: Oxycodone at a fixed dose with increasing pregabalin doses (Arm A)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Pregabalin at a fixed dose with increasing oxycodone doses (Arm B)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Arm A
Number of subjects: 75
Study: 20529333

Group type: EXPERIMENTAL
Intervention: BCG
Number of subjects: 137

Group type: COMPARATOR
Intervention: BEXIDEM
Number of subjects: 137
Study: 18955945

Group type: EXPERIMENTAL
Intervention: Ziprasidone, median dose 120 mg/day at endpoint
Number of subjects: 185
Study: 16822126

Group type: EXPERIMENTAL
Intervention: Stronger environmental coupling (2 beats per cycle)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Weaker environmental coupling (1 beat per cycle)
Number of subjects: 0
Study: 12814389

Group type: EXPERIMENTAL
Intervention: Folic acid, pyridoxine and cyanocobalamin for 3 months (n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No treatment (n = 30)
Number of subjects: 60
Study: 10770814

Group type: EXPERIMENTAL
Intervention: Elective anti-pseudomonal antibiotic treatment (4 treatments per year)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Symptomatic treatment (3 treatments per year)
Number of subjects: 60
Study: 8867773

Group type: EXPERIMENTAL
Intervention: Human Insulin (HI)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Porcine Insulin (PI)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 9
Study: 1632252

Group type: EXPERIMENTAL
Intervention: Erythromycin 0.5 g x 2
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 6742612

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (16 mg/day given orally for 7 days)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31610946

Group type: EXPERIMENTAL
Intervention: Direct surgeon-controlled image acquisition using a foot pedal (n = 52)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Indirect image acquisition by a radiology technician (n = 48)
Number of subjects: 100
Study: 30562392

Group type: EXPERIMENTAL
Intervention: Magne B6 (Mg–vitamin B6); daily dose 300 mg magnesium and 30 mg vitamin B6
Number of subjects: 264

Group type: COMPARATOR
Intervention: Magnespasmyl (Mg); daily dose 300 mg magnesium
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Magne B6 (Mg–vitamin B6)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Magnespasmyl (Mg)
Number of subjects: 264
Study: 26297055

Group type: EXPERIMENTAL
Intervention: Laparoscopic repair (LR)
Number of subjects: 119
Study: 25599775

Group type: EXPERIMENTAL
Intervention: Ketamine + Propofol (0.5 mg/kg ketamine + 1 mg/kg propofol)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Alfentanil + Propofol (10 mg/kg alfentanil + 1 mg/kg propofol)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Ketamine + Propofol
Number of subjects: 70
Study: 21617993

Group type: EXPERIMENTAL
Intervention: Teriparatide plus calcium and vitamin D
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Raloxifene plus calcium and vitamin D
Number of subjects: 0

Group type: COMPARATOR
Intervention: Calcium and vitamin D alone
Number of subjects: 0
Study: 19067673

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg daily for 8 weeks
Number of subjects: 64
Study: 17985060

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (20g/d during week 1 decreasing to 10g/d at week 2)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Creatine supplementation
Number of subjects: 15
Study: 15784478

Group type: EXPERIMENTAL
Intervention: n-3 PUFAs (fish oil) enterally (3.3g/day for 5-7 days)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (no n-3 PUFAs)
Number of subjects: 28
Study: 11860726

Group type: EXPERIMENTAL
Intervention: 100 g dried plums
Number of subjects: 58

Group type: COMPARATOR
Intervention: 75 g dried apples
Number of subjects: 58
Study: 10103297

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (250 microg/dose)
Number of subjects: 427

Group type: COMPARATOR
Intervention: Normal saline (1 mL/dose)
Number of subjects: 427
Study: 7576678

Group type: EXPERIMENTAL
Intervention: Macintosh laryngoscope
Number of subjects: 24

Group type: COMPARATOR
Intervention: Augustine guide
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 24
Study: 1712836

Group type: COMPARATOR
Intervention: MOPP
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: MOPP/CABS
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 125
Study: 6137307

Group type: EXPERIMENTAL
Intervention: Leucine infusion (300 mumol/min for 150 min)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Leucine plus glucose infusion (2.2 mmol/min)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Leucine, somatostatin (7 micrograms/min) and glucagon (1 ng/min) infusion
Number of subjects: 18
Study: 30318190

Group type: EXPERIMENTAL
Intervention: Flixweed
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Fig
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study: 29793558

Group type: EXPERIMENTAL
Intervention: Nacadia® NBT (NNBT)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Specialised Treatment for Severe Bodily Distress Syndromes (STreSS)
Number of subjects: 84
Study: 27276804

Group type: EXPERIMENTAL
Intervention: Semitendinous and gracilis transfer
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (no MCL injury)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Comparison between injury and control groups
Number of subjects: 29